Loading data for NVZMY — first visit, this takes a few seconds.
Novozymes A/S (NVZMY)
OTC Markets OTCPK: NVZMY
· Real-Time Price · USD
65.80
-1.37 (-2.04%)
At close: Sep 11, 2026, 6:33 PM
The price, the headline numbers and the latest news, in one place.
Novozymes A/S (NVZMY) Stock Price, Analysis & Data
No data available
| Bid | 65.6 |
| Market Cap | 30.9B |
| Revenue (ttm) | 4.3B |
| Net Income (ttm) | 632M |
| 0.63 | |
| 1.58 | |
| 41.98 | |
| 24.26 | |
| P/B (ttm) | 2.39 |
| P/S (ttm) | 7.20 |
| Earnings Date | Feb 24, 2027 |
| Ask | 65.84 |
| Volume | 1,200 |
| Avg. Volume (20D) | 30,883 |
| Open | 66.01 |
| Previous Close | 67.17 |
| Day's Range | 65.70 - 66.01 |
| 52-Week Range | 49.90 - 75.27 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | $1.02 (1.51%) |
| Ex-Dividend Date | Aug 31, 2026 |
About NVZMY
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including bi...
Industry Specialty Chemicals
Sector Basic Materials
IPO Date Jan 20, 2010
Employees 10,933
Stock Exchange OTC Markets OTCPK
Ticker Symbol NVZMY
Website https://www.novonesis.com
Financial Performance
In 2025, Novozymes A/S's revenue was 4.16B, an increase of 8.45% compared to the previous year's 3.83B. Earnings were 583.6M, an increase of 90.84%.
Financial StatementsEarnings Surprise
Novozymes A/S has released their quarterly earnings on Feb 1, 2024:
- Revenue of $1.12B misses estimates by $0, with 3.58% YoY growth.
- EPS of 0.44 misses estimates by 0.00, with -8.33% YoY decline.
Novozymes A/S is scheduled to release its earnings on Feb 24, 2027, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
